Show simple item record

dc.contributor.authorChaguza, Chrispinen_US
dc.contributor.authorCornick, Jennifer E.en_US
dc.contributor.authorHarris, Simon R.en_US
dc.contributor.authorAndam, Cheryl P.en_US
dc.contributor.authorBricio-Moreno, Lauraen_US
dc.contributor.authorYang, Marieen_US
dc.contributor.authorYalcin, Feyruzen_US
dc.contributor.authorOusmane, Sanien_US
dc.contributor.authorGovindpersad, Shanilen_US
dc.contributor.authorSenghore, Madikayen_US
dc.contributor.authorEbruke, Chineloen_US
dc.contributor.authorDu Plessis, Mignonen_US
dc.contributor.authorKiran, Anmol M.en_US
dc.contributor.authorPluschke, Gerden_US
dc.contributor.authorSigauque, Betuelen_US
dc.contributor.authorMcGee, Lesleyen_US
dc.contributor.authorKlugman, Keith P.en_US
dc.contributor.authorTurner, Paulen_US
dc.contributor.authorCorander, Jukkaen_US
dc.contributor.authorParkhill, Julianen_US
dc.contributor.authorCollard, Jean-Marcen_US
dc.contributor.authorAntonio, Martinen_US
dc.contributor.authorvon Gottberg, Anneen_US
dc.contributor.authorHeyderman, Robert S.en_US
dc.contributor.authorFrench, Neilen_US
dc.contributor.authorKadioglu, Arasen_US
dc.contributor.authorHanage, William P.en_US
dc.contributor.authorEverett, Dean B.en_US
dc.contributor.authorBentley, Stephen D.en_US
dc.date.accessioned2016-12-02T15:25:39Z
dc.date.issued2016en_US
dc.identifier.citationChaguza, C., J. E. Cornick, S. R. Harris, C. P. Andam, L. Bricio-Moreno, M. Yang, F. Yalcin, et al. 2016. “Understanding pneumococcal serotype 1 biology through population genomic analysis.” BMC Infectious Diseases 16 (1): 649. doi:10.1186/s12879-016-1987-z. http://dx.doi.org/10.1186/s12879-016-1987-z.en
dc.identifier.issn1471-2334en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:29626172
dc.description.abstractBackground: Pneumococcus kills over one million children annually and over 90 % of these deaths occur in low-income countries especially in Sub-Saharan Africa (SSA) where HIV exacerbates the disease burden. In SSA, serotype 1 pneumococci particularly the endemic ST217 clone, causes majority of the pneumococcal disease burden. To understand the evolution of the virulent ST217 clone, we analysed ST217 whole genomes from isolates sampled from African and Asian countries. Methods: We analysed 226 whole genome sequences from the ST217 lineage sampled from 9 African and 4 Asian countries. We constructed a whole genome alignment and used it for phylogenetic and coalescent analyses. We also screened the genomes to determine presence of antibiotic resistance conferring genes. Results: Population structure analysis grouped the ST217 isolates into five sequence clusters (SCs), which were highly associated with different geographical regions and showed limited intracontinental and intercontinental spread. The SCs showed lower than expected genomic sequence, which suggested strong purifying selection and small population sizes caused by bottlenecks. Recombination rates varied between the SCs but were lower than in other successful clones such as PMEN1. African isolates showed higher prevalence of antibiotic resistance genes than Asian isolates. Interestingly, certain West African isolates harbored a defective chloramphenicol and tetracycline resistance-conferring element (Tn5253) with a deletion in the loci encoding the chloramphenicol resistance gene (cat pC194), which caused lower chloramphenicol than tetracycline resistance. Furthermore, certain genes that promote colonisation were absent in the isolates, which may contribute to serotype 1’s rarity in carriage and consequently its lower recombination rates. Conclusions: The high phylogeographic diversity of the ST217 clone shows that this clone has been in circulation globally for a long time, which allowed its diversification and adaptation in different geographical regions. Such geographic adaptation reflects local variations in selection pressures in different locales. Further studies will be required to fully understand the biological mechanisms which makes the ST217 clone highly invasive but unable to successfully colonise the human nasopharynx for long durations which results in lower recombination rates. Electronic supplementary material The online version of this article (doi:10.1186/s12879-016-1987-z) contains supplementary material, which is available to authorized users.en
dc.language.isoen_USen
dc.publisherBioMed Centralen
dc.relation.isversionofdoi:10.1186/s12879-016-1987-zen
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC5100261/pdf/en
dash.licenseLAAen_US
dc.subjectPneumococcal serotype 1en
dc.subjectST217en
dc.subjectPhylogeographyen
dc.subjectEvolutionen
dc.subjectAntibiotic resistanceen
dc.titleUnderstanding pneumococcal serotype 1 biology through population genomic analysisen
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden
dc.relation.journalBMC Infectious Diseasesen
dash.depositing.authorHanage, William P.en_US
dc.date.available2016-12-02T15:25:39Z
dc.identifier.doi10.1186/s12879-016-1987-z*
dash.authorsorderedfalse
dash.contributor.affiliatedHanage, William


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record